Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaneka
Osaka/Nakanoshima Kita-ku, Osaka Prefecture, Japankaneka.co.jp ↗
- Ownership
- Public · 4118
- Employees
- ~11500
- Development stage
- Other
01
Overview
Kaneka Corporation is a diversified Japanese chemical company with significant operations in life sciences. Through its subsidiaries like Kaneka Eurogentec S.A. and partnerships/acquisitions such as AB-BIOTICS, it provides CDMO services for plasmid DNA, recombinant proteins, oligonucleotides and mRNA therapeutics/vaccines. It also develops medical devices and nutritional supplements including probiotics. The company has expanded its GMP manufacturing capacity to meet global demand for advanced biologics including mRNA-based drugs.
- Therapeutic areas
- CardiovascularGastroenterologyOncologyInfectious Diseases
- Modalities
- Small molecule (e.g., coenzyme Q10)Recombinant proteinOligonucleotidemRNA-based drugsPlasmid DNA therapyProbiotic (Live biotherapeutic product therapy)Medical devices (Device)
- Industry
- Contract Manufacturing Organization
02
Partnerships
AB-BIOTICS partnership/acquisitioncollaborations with pharmaceutical companies globally through CDMO businesspartnership with ESM for cerebrovascular medical device development
03
Financials
- Market cap
- $2.3B
- Total revenue
- $5.1B
- Enterprise value
- $3.4B
Beyond the preview
Go deeper on Kaneka.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kaneka.